2024 Grantees

Raul Jobava, Ph.D.
Yale University
Raul is a postdoctoral associate in the laboratory of Joan Steitz, Ph.D. at Yale University, where he studies terminal uridylyltransferases, the enzymes that promote RNA degradation. His long-term career goal is to combine integrative structural biology techniques with high-throughput molecular genetics to help lay the groundwork for drug development. He earned his bachelor’s degree from Tbilisi State Medical University in the Republic of Georgia, followed by a Ph.D. in Biochemistry from Case Western Reserve University in Cleveland, OH.

Jonathan D. Lee, Ph.D.
Beth Israel Deaconess Medical
Jonathan is a current postdoctoral fellow in the laboratory of Frank Slack, Ph.D. at Beth Israel Deaconess Medical Center at Harvard. He works to develop new tools and technologies to characterize the sets of transcription factors and regulatory RNAs dysregulated in difficult-to-treat cancers, with a current focus on acute myeloid leukemia. He received his A.B. and A.M. in Chemistry, S.M. in Applied Mathematics, and Ph.D. in Biology and Biomedical Science at Harvard University in Cambridge, MA.

Dr. Lee is the Hope Funds for Cancer Research Chiles Family Fellow

Adrienne Vancura Ph.D.
Whitehead Institute at MIT
Adrienne is a postdoctoral fellow in the laboratory of Richard A. Young, Ph.D., at the Whitehead Institute for Biomedical Research at MIT. She is currently working on transcription factors which harbor novel RNA binding domains, and how these interactions govern the structure of genomes. Her goal is to be an independent investigator exploring RNA molecules and their versatile functions within a cell. Dr. Vancura received her B.S. and Ph.D. in Biology at the University of Bern, and her M.S. in Biochemistry and Cancer Biology at the University of Amsterdam.

Dr. Vancura is the Hope Funds for Cancer Research Parks Family Fellow